Breast Cancer Gene-Expression Miner v4.0
Published annotated data
Published genomic data
Molecular subtype classification
Gene expression analyses
HOW TO CITE US
Targeted expression analysis
Enter input gene(s) and choose one of the following options:
Fill the textbox with actualised* gene symbol(s).
For more than two genes, identifiers must be separated by ";" (e.g.: UBE2C;LMNB1).
*: see actualised web databases (e.g.:
(items must be separated by ";" (min: 1 - max: 10))
Choose one of the radio button to select which splitting method you want to explore for all patients:
"Receptor statuses": oestrogen, progesterone and HER2 receptors status by immunohistochemistry (IHC).
"Nodal status": Node-positive (N+) versus Node-negative (N-).
"SBR": Scarff Bloom & Richardson grade (1 vs 2 vs 3)
"NPI": Nottingham Prognostic Index (1 vs 2 vs 3)
"Age": case 1: [≤40 / 40-70 / ≥70 years old] and case 2: [≤51 / >51 years old] (age at menopause in western industrialised countries)
"Molecular subtype": RMSPC as Robust Molecular Subtype Predictors Classification based on patients classified in the same molecular subtype with the six classifications.
"Basal-like and/or TNBC": basal-like subtype (PAM50) status and/or Triple Negative Breast Cancer status by IHC.
More information about molecular subtypes
Receptor statuses (ER+ vs ER-, PR+ vs PR-, HER2+ vs HER2- by IHC)
Nodal status (N+ vs N-)
SBR (SBR1 vs SBR2 vs SBR3)
NPI (NPI1 vs NPI2 vs NPI3)
Age (≤40/40-70/≥70 and ≤51/>51)
Basal-like (PAM50) and/or TNBC (IHC)
Request in process...